Importantly, TEdeff tumors of kidney cancers and melanomas had higher infiltration by T-cells (judged by the expression of CD247) (see Supplementary Fig 9), suggesting that the resistance to immune attack is probably at the level downstream of T-cell activation and infiltration, reminiscent of tumors progressing on immunotherapy45. This evidence concerns the gene CD247 and kidney cancer.